Filter
618
Filtered Results: 618
Text search:
U.
Williams
Featured
Recommendations
48
New Publications
111
Language
Document type
No document type
333
Studies & Reports
135
Guidelines
95
Manuals
26
Strategic & Response Plan
13
Training Material
7
Fact sheets
6
Resource Platforms
2
Situation Updates
1
Countries / Regions
Global
36
Latin America and the Carribbean
15
Russia
14
Western and Central Europe
13
South Africa
11
Uganda
11
Africa
10
India
10
Ukraine
9
Nigeria
7
Germany
7
Eastern Europe
7
Kenya
6
El Salvador
6
Indonesia
6
Peru
5
USA
5
Venezuela
5
Middle East and North Africa
5
Argentina
5
Brazil
5
South Sudan
5
Liberia
5
Nepal
4
Colombia
4
Lesotho
4
Ghana
4
Syria
4
Philippines
4
Tanzania
4
Zambia
4
Myanmar / Burma
4
Sierra Leone
3
Chile
3
Senegal
3
Zimbabwe
3
Yemen
3
Ethiopia
3
Ecuador
3
Rwanda
2
Burkina Faso
2
Guinea
2
Paraguay
2
Spain
2
Lebanon
2
Bangladesh
2
Sudan
2
Iraq
2
Mexico
1
Benin
1
China
1
Cameroon
1
Malawi
1
Qatar
1
Mozambique
1
Haiti
1
Asia
1
Dominican Republic
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
Western Pacific Region
1
United Kingdom
1
East and Southern Africa
1
Latvia
1
Bolivia
1
Vietnam
1
Nicaragua
1
Sri Lanka
1
Namibia
1
Central African Republic
1
Honduras
1
Mali
1
Botswana
1
Eswatini/ Swaziland
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
142
Clinical Guidelines
69
Public Health
36
Women & Child Health
34
Key Resources
18
Pharmacy & Technologies
7
Capacity Building
4
Toolboxes
Mental Health
114
COVID-19
71
TB
62
HIV
32
Planetary Health
27
NCDs
24
Disability
21
Caregiver
19
NTDs
19
AMR
15
Refugee
13
Pharmacy
10
Rapid Response
9
Ebola
9
Conflict
7
Zika
7
Natural Hazards
6
Health Financing Toolbox
6
Global Health Education
6
Specific Hazards
5
Social Ethics
5
Cholera
1
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Snakebite envenoming is a serious public health problem in Central America, where approximately 5,500 cases occur every year. Panama has the highest incidence and El Salvador the lowest. The majority, and most severe, cases are inflicted by the pit viper Bothrops asper (family Viperidae), locally kn...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas disease transmission is also expected over the next several decades under climate chan...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
The knowledge guide is the second publication in the Self-care competency framework to support health and care workers.
This describes how health and care workers can apply each of the 10 competency standards in their work, detailing the necessary knowledge, skills and attitudes that underpin the...
This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic t...
There is growing understanding and high-level endorsement of the importance of strong collaborative multisectoral approaches to address a broad range of social, economic and governance issues for the prevention and control of noncommunicable disease (NCDs) and mental health conditions. In 2019, Worl...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
